QT
AKBA icon

Quantbot Technologies’s Akebia Therapeutics AKBA Stock Holding History

Quantbot Technologies’s Portfolio AKBA Stock Details AKBA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-12,095
Closed -$16.8K – 1901
2026
Q1 		$16.8K Buy
+12,095
New +$16.6K ﹤0.01% 1500
2024
Q4 		– Sell
-2,116
Closed -$2.79K – 1437
2024
Q3 		$2.79K Buy
+2,116
New +$2.83K ﹤0.01% 1380
2020
Q4 		– Sell
-4,800
Closed -$12K – 1247
2020
Q3 		$12K Buy
4,800
+4,300
+860% +$37.7K ﹤0.01% 1077
2020
Q2 		$6K Buy
+500
New +$5.17K ﹤0.01% 981
2020
Q1 		– Sell
-4,300
Closed -$27K – 872
2019
Q4 		$27K Buy
+4,300
New +$20.4K ﹤0.01% 1028
2015
Q4 		– Sell
-10,970
Closed -$105K – 1048
2015
Q3 		$105K Buy
+10,970
New +$101K 0.02% 747

Other funds holding AKBA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Quantbot Technologies's AKBA Position: Q2 2026 in Review

Quantbot Technologies sold out of Akebia Therapeutics (AKBA) in Q2 2026, closing a stake of 12,095 shares — an estimated $16.8K sold.

Quantbot Technologies first reported a position in AKBA in Q3 2015 and held it in 6 quarters. The position peaked at $105K in Q3 2015. 171 funds tracked by Wall St. Rank hold AKBA as of Q2 2026.

  • Quantbot Technologies reported no remaining Akebia Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Quantbot Technologies sold 12,095 Akebia Therapeutics shares in Q2 2026, an estimated $16.8K.
  • Quantbot Technologies first reported a position in Akebia Therapeutics in Q3 2015 and held it in 6 quarters.
  • Quantbot Technologies's Akebia Therapeutics position peaked at $105K in Q3 2015.
  • 171 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.